1. Introduction: The Renaissance of Wound Microbiology
Wound management is currently navigating a “renaissance” in the application of antiseptic agents. This shift is driven by the global escalation of multi-drug resistant organisms (MDROs) and the significant risks associated with topical antibiotics, including high rates of sensitization and the promotion of resistance.
Modern clinical practice has moved away from microbiostatic topical antibiotics toward advanced, well-tolerated xenobiotic antiseptics. These microbicidal agents offer a broad spectrum of activity with no observed resistance development, as they utilize unspecific mechanisms such as the irreversible destruction of the bacterial cell membrane or the blockage of negative surface charges. This return to antisepsis represents an evidence-based necessity for the modern wound care team.
2. Identifying the Microbial Status: A Hierarchy of Risk
Accurate assessment of the microbial-host interaction is the first step in effective management. We classify the microbial status of a wound into five distinct levels:
| Term | Clinical Characteristics | Host Reaction |
| Contamination | Microorganisms present and attached to tissue surface. | No initial proliferation or host reaction. |
| Colonization | Microorganisms are present and proliferating. | No significant immunological host reaction. |
| Critical Colonization | Proliferation is high; toxins begin to delay healing. | No “classical” signs of infection; stagnation of healing. |
| Local Infection | Redness (erythema 1–2 cm), edema, and local warmth. | Observable host reaction; increased exudate and pain. |
| Systemic Infection | Spreading inflammatory reaction beyond the local site. | Fever, leukocytosis, and elevated C-reactive protein. |
3. Clinical Indications: When are Diagnostics and Treatment Necessary?
As a matter of clinical priority, treatment must be predicated on a strict indication to avoid iatrogenic complications.
Microbiological Diagnostics The German Society for Wound Healing and Wound Treatment recommends that microbiological diagnostics for chronic wounds are indicated only when there are clinical signs of a systemic infectious event originating from the wound area. Routine swabbing of non-infected chronic wounds is considered an inefficient use of resources and lacks clinical utility.
Initiating Treatment The Wounds-at-Risk (WAR) Score serves as our primary decision-making tool for justifying antiseptic treatment. Beyond the score, the clinical team should monitor for these specific indicators of infection:
- Erythema (redness extending 1–2 cm from the margin).
- Edema (localized swelling).
- Increased exudate quantity and viscosity.
- Stagnation in wound healing.
- Perceptible odor (indicating anaerobic activity or specific pathogens).
4. The WAR Score: A Practical Assessment for Clinical Teams
The WAR Score is not merely a classification—it is a preventive trigger. Antiseptic treatment is clinically justified if the total score is >= 3 points. It is vital to understand the cumulative nature of these risks. For instance, a 90-year-old patient (1pt) with diabetes (1pt) and a wound depth of 2 cm (1pt) reaches the 3-point threshold for antiseptic treatment even in the absence of overt infection signs.
- Class 1 (1 point per risk): Diabetes mellitus, patient age >80 years, wound depth >1.5 cm, wound dimensions >10 cm², wounds persisting >1 year, or immunosuppressive therapy (e.g., glucocorticoids).
- Class 2 (2 points per risk): Heavily contaminated acute wounds, or bite, stab, and gunshot wounds penetrating 1.5–3.5 cm.
- Class 3 (3 points per risk): Severe immunodeficiency (AIDS, stem cell transplant), burns >15% BSA, wounds with direct connection to organs/joints, or bite/stab/gunshot wounds penetrating >3.5 cm.
5. Comparative Analysis of Antiseptic Agents
Selection of an agent must be tailored to the specific etiology and anatomical location of the wound.
| Agent | Onset Time | Key Advantage | Primary Indication |
| Polihexanide (PHMB) | 30 min (0.1%) to 3h (0.04%)* | Promotes healing; analgesic; virtually detoxified. | 1st choice for infected chronic wounds and burns. |
| Octenidine (OCT/PE) | 30 min to 10 hours* | Deep action; remanent effect; superior for biofilms. | 1st choice for MDRO decolonization (MRSA/VRE). |
| Hypochlorite (NaOCl/HOCl) | 30 sec to 5 min | Physiological mechanism; high speed; eco-friendly. | 1st choice for intensive cleansing and biofilm removal. |
| PVP-I (Iodophore) | 30 min* | High penetration; broad microbicidal spectrum. | 1st choice for acute bite, stab, and gunshot wounds. |
*Onset times are dependent on organic load. PHMB and OCT can take up to 10 hours under heavy protein load in test models.
Clinical Consultant Pearls:
- Hypochlorite Safety: This agent utilizes a “physiological bactericidal mechanism” mimicking the myeloperoxidase process in human phagocytosis. This high level of biocompatibility makes it the only safe choice for CNS or peritoneal exposure.
- PVP-I Distinctions: For deep penetration in acute injuries, use alcohol-based PVP-I. However, in cases of heavily destroyed tissue (e.g., car crashes or explosions), only aqueous-based PVP-I should be utilized.
- Hypergranulation Management: PVP-I is highly effective for pathological hypergranulation. Applying iodine gauze for 2–3 weeks can transform fragile, bleeding tissue into stable, healthy granulation.
6. The Problem of Polymicrobial Wounds and Resistance
Topical antibiotics like mupirocin should be strictly avoided for general wound care. Widespread “over-the-counter” use has driven mupirocin resistance to exceed 20% in some hospital-associated MRSA strains. Note that mupirocin remains a specialized tool for nasal vestibule decolonization, but it is largely obsolete as a primary wound antiseptic.
Antiseptics remain vastly more effective than traditional antibiotics. For example, minimal inhibitory concentration (MIC) data shows that OCT and PHMB are significantly more potent against S. aureus, MRSA, and P. aeruginosa than systemic antibiotics like Cefuroxime.
7. Essential Rules for Clinical Application
To ensure safety and therapeutic efficacy, adhere to the following checklist:
- [ ] Determine Etiology: Antiseptics cannot compensate for an unaddressed primary cause (e.g., pressure or arterial insufficiency).
- [ ] Cleansing First: Prioritize mechanical debridement; antiseptics fail if they cannot penetrate debris or slough.
- [ ] Two-Week Review: If the wound shows no improvement after 14 days of antiseptic application, re-evaluate the therapeutic regimen and underlying diagnostics.
- [ ] Continuous Drainage & Pressure Warning: Surface-active antiseptics, specifically Octenidine (OCT), must never be applied under pressure (e.g., via syringe) into deep tissue, puncture wounds, or abscess cavities. Misapplication has led to severe iatrogenic injury, including edematous swelling and the necessity for surgical revision.
- [ ] Structure Restrictions: Do not apply OCT or PHMB to hyaline cartilage or CNS structures.
8. Summary Table: Indication-Based Selection
| Indication | 1st Choice Agent |
| Burns (Conservative and Grade II) | Polihexanide (PHMB) |
| Bite / Stab / Gunshot Wounds | PVP-I (Alcohol-based for penetration) |
| MDRO (MRSA/VRE) Colonization | Octenidine (OCT/PE) |
| Peritoneal Lavage / CNS Exposure | Hypochlorite (NaOCl/HOCl) |
| Intensive Biofilm Removal | Hypochlorite or PHMB/Betaine |
| Chronic Wound Maintenance | Polihexanide (PHMB) |